PCP (phencyclidine) is considered highly addictive, classified as a Schedule II controlled substance alongside cocaine and methamphetamine due to its high potential for abuse. Its addiction profile is unusual, though. PCP produces strong psychological dependence, with intense cravings and compulsive use, but lacks the clearly defined physical withdrawal syndrome seen with drugs like opioids or alcohol.
How PCP Hooks the Brain
PCP’s addictive potential comes from its ability to disrupt multiple brain systems at once. It blocks NMDA receptors, which are involved in learning, memory, and how neurons communicate through glutamate, the brain’s primary excitatory chemical. But the piece that matters most for addiction is what happens to dopamine.
PCP increases dopamine activity in the mesolimbic system, the brain’s reward pathway. This is the same circuit hijacked by cocaine, methamphetamine, and other highly addictive stimulants. When dopamine floods this pathway, the brain registers the experience as intensely rewarding and worth repeating. PCP also alters the signaling of GABA, the brain’s main calming chemical. The result is a multi-system neurochemical imbalance that reinforces continued use and makes the drug’s effects feel uniquely compelling to some users.
This combination of reward-system activation and broad neurochemical disruption helps explain why PCP use often escalates. People develop tolerance, needing larger doses to achieve the same dissociative or euphoric effects. Animal studies consistently show both tolerance and dependence developing with repeated exposure.
Psychological Dependence Is the Primary Driver
What makes PCP addiction distinctive is how heavily it leans on psychological rather than physical mechanisms. The National Drug Intelligence Center describes PCP as a drug whose use “often results in psychological dependence, craving, and compulsive behavior.” Users may feel an overwhelming urge to keep using despite clear negative consequences in their relationships, work, and mental health.
Physical withdrawal from PCP has been observed in animal studies but has not been formally documented in humans. This doesn’t mean quitting is easy. Psychological cravings can be just as powerful as physical withdrawal in sustaining a drug habit, and in some ways harder to treat because there’s no clear timeline for when they’ll subside. People who stop using PCP often describe persistent urges that can last weeks or months, along with depression, anxiety, and difficulty experiencing pleasure from everyday activities.
How PCP Compares to Other Drugs
PCP sits in an unusual place on the addiction spectrum. Its Schedule II classification puts it in the same legal category as cocaine and methamphetamine, reflecting a recognized high potential for abuse and severe dependence. Most classic hallucinogens like psilocybin and LSD are Schedule I but are generally considered to have low addiction potential because they don’t strongly activate dopamine reward pathways the way PCP does.
Ketamine, PCP’s closest chemical relative, works on similar brain receptors but is generally considered less addictive. Both are dissociative anesthetics, but PCP’s effects last significantly longer and its impact on dopamine is more pronounced. That said, ketamine dependence is a recognized and growing problem, particularly with frequent recreational use.
Compared to opioids or benzodiazepines, PCP produces less dramatic physical withdrawal. But its psychological grip can be just as difficult to break, and its tendency to cause erratic, dangerous behavior during intoxication adds a layer of risk that many other drugs don’t carry.
Signs of PCP Use Disorder
PCP use disorder is a formal diagnosis. It requires at least two of the following patterns within a 12-month period: using more PCP or using it longer than intended, wanting to cut back but being unable to, spending large amounts of time obtaining or recovering from the drug, experiencing strong cravings, failing to meet responsibilities at work or school, continuing use despite relationship problems it’s causing, giving up activities that used to matter, using in physically dangerous situations (like driving), continuing despite knowing it’s worsening a physical or psychological problem, or developing tolerance.
The severity scales with how many of those patterns are present. Two to three signs indicates a mild disorder, four to five is moderate, and six or more is severe. Notably, withdrawal is not included as a diagnostic criterion because it hasn’t been established in human users.
Why People Keep Using Despite the Risks
PCP’s effects are unpredictable and sometimes terrifying, which raises a reasonable question: why would anyone use it repeatedly? The answer lies partly in the drug’s dissociative properties. At lower doses, PCP can produce feelings of euphoria, detachment from pain, and a sense of invincibility or heightened strength. For some users, that dissociation from reality feels like relief, particularly if they’re dealing with trauma, chronic stress, or other mental health challenges.
The dopamine surge reinforces this cycle at a neurological level. Even when a person has had frightening or violent experiences while intoxicated, the reward circuitry can still drive them back to the drug. Over time, PCP also disrupts the brain’s glutamate signaling in ways that impair judgment and decision-making, making it harder for users to accurately weigh the consequences of continued use. This creates a feedback loop where the drug gradually undermines the very cognitive abilities a person would need to recognize the problem and stop.
Repeated PCP use can also produce lasting psychiatric effects that resemble schizophrenia, including paranoia, disordered thinking, and hallucinations. These symptoms can persist for weeks or months after the last dose and may complicate recovery by making it harder for a person to engage with treatment or maintain stable relationships.